Jim Cramer says investors need to watch out for next week's economic data, COVID news and bank earnings. He's got your game plan.

Medicinova's clinical trials found that its ibudilast reduced the odds of heavy drinking over time by 45% relative to a placebo.

Nanox shares climbed after the medical-imaging-tech company applied to the FDA for clearance of a system that produces scans of human body parts.

Altimmune jumped after it reported progress from its Phase 1 trial of ALT-801, a drug for obesity and liver disease.

Altimmune says it doesn't expect 'a significant impact on the overall clinical development timeline.'

Sequoia Capital and Y Combinator have told startups that cutting costs is a priority.

Elon Musk will soon allow Dogecoin to purchase SpaceX merchandise.

The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.

Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.